These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26502636)

  • 1. Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.
    Sagar V; Pilakka-Kanthikeel S; Atluri VS; Ding H; Arias AY; Jayant RD; Kaushik A; Nair M
    J Biomed Nanotechnol; 2015 Oct; 11(10):1722-33. PubMed ID: 26502636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of the potent and highly selective mu opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice.
    Gulya K; Kriván M; Nyolczas N; Sarnyai Z; Kovács GL
    Eur J Pharmacol; 1988 Jun; 150(3):355-60. PubMed ID: 2901358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse.
    Sagar V; Atluri VS; Pilakka-Kanthikeel S; Nair M
    Mol Brain; 2016 May; 9(1):57. PubMed ID: 27216740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.
    Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Jan; 280(1):402-9. PubMed ID: 8996221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented cellular uptake of nanoparticles using tea catechins: effect of surface modification on nanoparticle-cell interaction.
    Lu YC; Luo PC; Huang CW; Leu YL; Wang TH; Wei KC; Wang HE; Ma YH
    Nanoscale; 2014 Sep; 6(17):10297-306. PubMed ID: 25069428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
    Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
    Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI
    NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
    Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
    J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.
    Pilakka-Kanthikeel S; Atluri VS; Sagar V; Saxena SK; Nair M
    PLoS One; 2013; 8(4):e62241. PubMed ID: 23653680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidance of Magnetic Nanocontainers for Treating Alzheimer's Disease Using an Electromagnetic, Targeted Drug-Delivery Actuator.
    Do TD; Ul Amin F; Noh Y; Kim MO; Yoon J
    J Biomed Nanotechnol; 2016 Mar; 12(3):569-74. PubMed ID: 27280254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumor treatment: in vitro evaluation of cytotoxicity and magnetohyperthermia efficacy.
    Estevanato LL; Da Silva JR; Falqueiro AM; Mosiniewicz-Szablewska E; Suchocki P; Tedesco AC; Morais PC; Lacava ZG
    Int J Nanomedicine; 2012; 7():5287-99. PubMed ID: 23055734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release nanoART formulation for the treatment of neuroAIDS.
    Jayant RD; Atluri VS; Agudelo M; Sagar V; Kaushik A; Nair M
    Int J Nanomedicine; 2015; 10():1077-93. PubMed ID: 25709433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting intracellular compartments by magnetic polymeric nanoparticles.
    Kocbek P; Kralj S; Kreft ME; Kristl J
    Eur J Pharm Sci; 2013 Sep; 50(1):130-8. PubMed ID: 23603023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier.
    Saiyed ZM; Gandhi NH; Nair MP
    Int J Nanomedicine; 2010 Apr; 5():157-66. PubMed ID: 20463931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS.
    Jayant RD; Atluri VSR; Tiwari S; Pilakka-Kanthikeel S; Kaushik A; Yndart A; Nair M
    J Neurovirol; 2017 Aug; 23(4):603-614. PubMed ID: 28762183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model.
    Dilnawaz F; Singh A; Mewar S; Sharma U; Jagannathan NR; Sahoo SK
    Biomaterials; 2012 Apr; 33(10):2936-51. PubMed ID: 22264522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
    Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
    Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field.
    Wen J; Jiang S; Chen Z; Zhao W; Yi Y; Yang R; Chen B
    Int J Nanomedicine; 2014; 9():2043-50. PubMed ID: 24790442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic targeting of nanoparticles across the intact blood-brain barrier.
    Kong SD; Lee J; Ramachandran S; Eliceiri BP; Shubayev VI; Lal R; Jin S
    J Control Release; 2012 Nov; 164(1):49-57. PubMed ID: 23063548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.